FDA Scrutiny of Compounded Drugs Continues

A flurry of guidance in recent months from the U.S. Food and Drug Administration regarding compounding of drugs indicates that the practice, which is increasingly an irritant to workers’ compensation payers, is under more scrutiny from the federal government. Among the latest FDA actions is the release of a draft guidance on compounded medications that are essentially copies of commercially available drugs, which, unlike compounded drugs, go through an FDA approval process. For the most part, compounding facilities aren’t allowed to produce those drugs, but exceptions may apply in...